United Therapeutics
UTHR
UTHR
521 hedge funds and large institutions have $10.4B invested in United Therapeutics in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 214 increasing their positions, 180 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less call options, than puts
Call options by funds: $270M | Put options by funds: $281M
2% less funds holding
Funds holding: 531 → 521 (-10)
10% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 60
Holders
521
Holding in Top 10
11
Calls
$270M
Puts
$281M
Top Buyers
1 | +$147M | |
2 | +$84.8M | |
3 | +$67.8M | |
4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$63.1M |
5 |
BlackRock
New York
|
+$62.6M |
Top Sellers
1 | -$299M | |
2 | -$88M | |
3 | -$87.7M | |
4 |
O
OrbiMed
New York
|
-$84.9M |
5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$84.1M |